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Abstract 
Treatment of UTI patients with aminoglycosides is a familiar incidence. Resistance of antibiotics is also a familiar 
incidence but it is alarming when it goes to a high ratio. The vital public health problem in developing country like 
Bangladesh is resistance of antibiotics to different types of bacteria causing UTI and the rates of these bacterial 
resistances are changing for various antibiotic therapy. Our aim was to assess the susceptible pattern of Gentamicin 
a drug of Aminoglycosides group against uropathogens. A total of 12943 urine samples were collected in 2016 
(Jan-Dec) and out of which 1236 (9.55%) were bacteriologically positive out of these isolated  95.1% were gram 
negative and 4.9% gram positive organism. Male were found more prone to get UTI under 10 years and between 
51-90 years of age and female were more affected in 10 to 50 years and over 90 years of age group. E. coli was 
the most prevalent (83.9%) isolate followed by Klebsiella spp. (6.7%), Staphylococcus aureus (2.6%), 
Pseudomonas spp. (2.2%), Enterococcus spp. (2.0%) and Proteus spp. (1.1%). The most predominant organism 
Acinetobacter spp. (100%) were found sensitive to Gentamicin in both male and female patients and Enterococcus 
spp. in male (62.5%) and female (58.8%) were found resistant.  Around 37.4% male and 32.5% female were found 
resistant to E.coli. 
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I. INTRODUCTION 
Antibiotic resistance is an increasing threat to life and morbidity and mortality. Urinary Tract Infection (UTI) is a 
predominant infection all over the world but it is more prevalent in developing south Asian countries like 
Bangladesh. Urinary Tract Infection (UTI) represents as one of the most common diseases encountered in medical 
practices these days and encompasses a broad range of clinical fields that are associated with a common finding 
of positive urine cultures. Besides every year about 150 million people are affected by UTIs. Worldwide at a cost 
of about US$6 billion and even UTIs have demonstrated significant morbidity and mortality. (1) 
They are the second most common types of infection in humans accounting for 8.3 million doctor’s visit 
annually in USA.(2) UTI can be nosocomially ubiquitous in clinical environment so that prevalence rate of 
uropathogens is being alarmingly accelerated.(1) Urinary tract infection is more common in female than male, 
because of the short length of the urethra and its proximity to anus. Pregnancy and sexual activity also make female 
more susceptible to UTI. Different factors like age, sex, immunosuppression and urological instruments may affect 
prevalence of UTIs.(3)  
To prevent these pathogens, different types of antibiotics and their super generations are used irrespectively 
with different doses in misused and overused forms. So uropathogens are getting resistant to efficacious drugs 
adopting different mechanisms of mutations and genetic transformations.(4) The etiology of UTIs and the antibiotic 
susceptibility of urinary pathogens, both in community and hospitals, have been changing over the past years and 
recently, the antibiotic resistance has become a major global problem.(5) A large proportion of uncontrolled 
antibiotic usage has contributed to the emergence of resistant bacterial infections.(6) 
The early introduction of effective drugs against bacterial infections in the last century has changed the 
medical behavior and has significantly reduced the mortality rates due to these agents. However, the widespread 
use of antibiotics has induced different mechanisms of bacteria resistance to these drugs.(7) Bacterial resistance is 
naturally developed, being a consequence of bacteria adaptation to the environment. The exposure of 
microorganisms to different antibiotics increases the selective pressure and favors the development of resistance.(8) 
The most frequently prescribed antibiotics to treat UTIs are sulfamethoxazole+trimethoprim, fluoroquinolones 
(ciprofloxacin or norfloxacin), 1st , 2nd and 3rd generations of cephalosporins, amoxicillin + clavulanate, 
Aminoglycosides and nitrofurantoin. (1) 
However, Gentamicin, sold under brand names Garamycin among others, is an antibiotic used to treat several 
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types of bacterial infections. This may include bone infections, endocarditis, pelvic inflammatory disease, 
meningitis, pneumonia, urinary tract infections, and sepsis among others.(8) Gentamicin was discovered in 1963.(9) 
It is made from the bacteria Micromonospora purpurea.(8) Gentamicin is on the World Health Organization's List 
of Essential Medicines, the most effective and safe medicines needed in a health system.(10) It is available as a 
generic medication.(11) The injectable's wholesale cost in the developing world in 2014 was between US$0.05 and 
US$0.58 per ml.(12) 
In addition to, Aminoglycosides like Gentamicin "irreversibly" bind to specific 30S-subunit proteins and 16S 
rRNA. Specifically Gentamicin binds to four nucleotides of 16S rRNA and a single amino acid of protein S12. 
This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S subunit. This region 
interacts with the wobble base in the anticodon of tRNA. This leads to interference with the initiation complex, 
misreading of mRNA so incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic 
peptides and the breakup of polysomes into nonfunctional monosomes.(13,14) 
It is the most effective drugs for UTI patients in Bangladesh for treatment of UTI patients. But now a days 
we see the drugs does not work against uropathogens as before works. Our aim of the study to see the state of 
susceptibility pattern of Gentamicin against Urinary Tract Infection patients in selected areas (Badda, Gulshan, 
Baridhara, Rampura, Doyagonj, Gandaria, Jatrabari, Sayedabad) of Dhaka, Bangladesh. 
 
II. MATERIALS AND METHODS 
Materials  
Study Design: A cross-sectional study. 
Study Location: This was a retrospective analysis of laboratory data routinely collected from the 
microbiology department of IBN SINA Diagnostic & Consultation Center, Badda, Dhaka-1212, Bangladesh from 
1st January, 2016 to 31st December, 2016. The total sample volumes were 12943. 
Methods 
Sample Collection and Bacteriological Assessment: Early morning midstream urine samples were 
collected aseptically from 12943 (Male-3638 & female-9305) patients. The urine samples were collected into 
sterile wide container (China) with screw cap tops. On the label were the name, age, sex and time of collection. 
All the patients were instructed on how to collect the urine samples aseptically and taken to the laboratory 
immediately for culture. In the diagnostic laboratory, each well mixed urine sample (1µL) was inoculated on 
MacConkey agar (Oxoid), Hichrome UTI agar (HiMedia) and Blood agar (Oxoid) media plate under class-II 
laminar airflow (NUVO Sanaji Malzemelzeni, Imalat Vc Ticaret A.S, Turkey). The inoculum on the plate was 
streaked out for discrete colonies with a sterile wire loop sterilized by auto loop sterilizer (Germany) following 
standard procedures.  The culture plates were incubated at 37°C by an incubator (Germany) for 48 hours and 
observed for the growth of bacteria through formation of colonies. All the bacteria were isolated and identified 
morphologically, microscopy (Japan) and biochemical tests like TSI (HiMedia), MIU (HiMedia) and Simmons 
Citrate (HiMedia) agar following standard procedures.(15) 
Antibiotic Susceptibility Assessment: The disc diffusion technique was used for antibacterial 
susceptibility testing of the isolates using commercial antibiotics containing discs. We used the commercial 
antibiotic disc Gentamicin (10µg, Oxoid). Interpretation of results was done using zone sizes. Zones of inhibition 
for Enterobacteriaceae, P. aeruginosa, Acinetobacter spp., and Staphylococcus spp. ≥15 mm was considered 
sensitive, 13-14 mm intermediate and ≤12 mm resistant, Isolates were classified as either sensitive or resistant 
based on the definition of the Clinical and Laboratory Standard Institute.(16) Some laboratory stains of known 
sensitivity of Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212, Escherichia coli ATCC 
25922, Pseudomonas aeruginosa ATCC 27853 and Streptococcus pneumoniae ATCC 49619 were used as quality 
control strains for the antimicrobial discs. 
Statistical Analysis: Data were assessed using the Statistical Package for Social Science (IBM SPSS Statistics, 
version 18, IBM Corporation, SPSS Inc. Chicago, III, USA).  
 
III.RESULTS 
The total 12943 urine samples collected from patients, 1236 (9.55%) samples were positive and 11707 (90.45%) 
samples were negative at 2016 (January-December) in selected areas (Badda, Gulshan, Baridhara, Rampura, 
Doyagonj, Gandaria,Jatrabari, Sayedabad, Dhaka, Bangladesh). 
Tabel-1: Distribution table of Urinary Tract Infection (UTI) patients by age groups and gender (n=1236) 
Age (Years) <10 
11-
20 
21-
30 
31-40 
41-
50 
51-60 
61-
70 
71-
80 
81-
90 
>90 
Male 53 05 19 16 26 38 73 38 05 02 
Female 103 83 181 113 149 130 124 56 14 08 
Total 156 88 200 129 175 168 197 94 19 10 
In our study, table-1 showed the distribution table of urinary tract infection affected patients by their age 
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groups and gender. The highest of the study subjects under goes to the 21-30 years age group (200 patients=181 
female + 19 male) and followed by 61-70 years age group (197 patients=124 female + 73 male), 41-50 years age 
group (175 patients=149 female + 26 male), 51-60 years age group (168 patients= 130 females + 38 males) and 
<10 years age group (156 patients= 103 females + 53 males) respectively.  Most prevalent frequency of female 
and male patients affected by uropathogens was found in 21-30 years and 61-70 years age group respectively.  
 
Figure-1: UTI percentage among different age groups of male (N=275) and female (N=961). 
The percentage of male patients were more porne besides female patients (19.3% > 10.7%) under 10 years 
age groups. In between 11-20, 21-30, 31-40 and 41-50 years of age group female UTI infection (8.6%, 18.8%, 
11.8% and 15.5% respectively) is higher than male (1.8%, 6.9%, 5.8% and 9.5% respectively).  In between 51-60, 
61-70 , 71-80 and 81-90 years age male infection (13.8%, 26.5%, 13.8% and 1.8% respectively) is higher than 
female (13.5%, 12.9%, 5.8 % and 1.5% respectively). Above 90 years age female infection (0.8%) is higher than 
male (0.7%) but here number of patients were very few.  
Table-2: Distribution of specific uropathogen mediated UTI among UTI patients 
Organisms Percentage (n=1236) 
Male Female Total 
E. coli 222(18.0%) 815(65.9%) 1037(83.9%) 
Klebsiella spp. 17(1.4%) 66(5.3%) 83(6.7%) 
Staphylococcus aureus 5(0.4%) 27(2.2%) 32(2.6%) 
Pseudomonas spp. 15(1.2%) 12(1.0%) 27(2.2%) 
Enterococcus spp. 8(0.6%) 17(1.4%) 25(2.0%) 
Proteus spp. 6(0.5%) 8(0.6%) 14(1.1%) 
Enterobacter spp. 1(0.1%) 9(0.7%) 10(0.8%) 
Acinetobacter spp. 1(0.1%) 1(0.1%) 2(0.2%) 
Serretia spp. 0(0.0%) 2(0.2%) 2(0.2%) 
Staphylococcus saprophyticus 0(0.0%) 2(0.2%) 2(0.2%) 
Citrobacter spp. 0(0.0%) 1(0.1%) 1(0.1%) 
Streptococcus Group B 0(0.0%) 1(0.1%) 1(0.1%) 
Total 275(22.2%) 961(77.8%) 1236(100.0%) 
Table 2 showed that the most predominant organism E. coli 1037(male 222 and female 815) found in UTI 
patients. According to number or percentage distribution, the second prevalent organism was Klebsiella spp. 83 
(male 17 & female 66) followed by Staphylococcus aureus 32 (male 5 and female 27), Pseudomonas spp. 27 (male 
15 and female 12), Enterococcus spp. 25 (male 8 and female 17), Proteus spp. 14 (male 6 and female 8) and 
Enterobacter spp. 10 (male 1 and female 9) respectively. In total bacteriologically positive cases, the most prone 
organism in male and female were E. coli (18.0% and 65.9 %) respectively. Moreover, all the isolated organisms 
were found highest in female except Pseudomonas spp. in contrast male patients. On the other hand the study 
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showed that the total 22.2% male patients and 77.8% female patients were found.  
Table-3: Prevalence of different uropathogens among male and female patients. 
Organisms 
Male (n=275) Female (n=961) 
Number Percentage Number Percentage 
E.coli 222 80.7% 815 84.8% 
Klebsiella spp. 17 6.2% 66 6.9% 
Staphylococcus aureus 5 1.8% 27 2.8% 
Pseudomonas spp 15 5.5% 12 1.2% 
Enterococcus spp. 8 2.9% 17 1.8% 
Enterobacter spp. 1 0.4% 9 0.9% 
Proteus spp. 6 2.2% 8 0.8% 
Serretia spp. 0 0.0% 2 0.2% 
Staphylococcus saprophyticus 0 0.0% 2 0.2% 
Acinetobacter spp. 1 0.4% 1 0.1% 
Citrobacter spp. 0 0.0% 1 0.1% 
Streptococcus Group B 0 0.0% 1 0.1% 
Total 275 100.0% 961 100.0% 
In this study, the urinary tract infections of female patients (961) were more prone to male patients (275). In 
male, the most predominant uropathogen were E. coli (80.7%) followed by Klebsiella spp. (6.2%), Pseudomonas 
spp. (5.5%), Enterococcus spp. (2.9%), Staphylococcus aureus (1.8%). In female, the most prevalent uropathogens 
were E. coli (84.8%) followed by Klebsiella spp. (6.9%), Staphylococcus aureus (2.8%), Enterococcus spp. (1.8%),   
Pseudomonas spp. (1.2%). The study noted that female patients were more infected by all of the isolated organism 
(E. coli, Klebsiella spp., Staphylococcus aureus, Enterobacter spp, Serretia spp., Staphylococcus saprophyticus, 
Citrobacter spp. and Streptococcus Group B) except some organisms (Pseudomonas spp. and Enterococcus spp., 
Proteus spp. and Acinetobacter spp.) but here the number were very few.  
Table-4: Susceptibility pattern of Gentamicin against uropathogens among male UTI patients (n=275) 
Name of organisms 
Sensitive Resistant 
Number Percentage Number Percentage 
E. coli 139 62.6% 83 37.4% 
Proteus spp. 5 83.3% 1 16.7% 
Pseudomonas spp. 8 53.3% 7 46.7% 
Klebsiella spp. 11 64.7% 6 35.3% 
Enterobacter spp. 1 100.0% 0 0.0% 
Staphylococcus aureus 2 40.0% 3 60.0% 
Enterococcus spp. 3 37.5% 5 62.5% 
Acinetobacter spp 1 100.0% 0 0.0% 
Total 170 61.8% 105 38.2% 
Table-4 showed that Gentamicin sensitive against isolated uropathogenic bacteria in total male patients were 
61.8% and rest of resistant 38.2%. All of them (100%) Acinetobacter spp. and Enterobacter spp. were sensitive to 
Gentamicin but here the numbers were very few. On the other hand the most prevalent resistant organism was 
Enterococcus spp. (62.5%). In contrast of frequency, E. coli was the most significant organism which was 62.6 % 
sensitive and 37.4 % resistant to Gentamicin. However, the other isolated bacteria’s sensitive pattern to Gentamicin 
followed by Proteus spp.(83.3%), Pseudomonas spp. (53.3%), Klebsiella spp. (64.7%), Staphylococcus aureus 
(40%) and Enterococcus spp. (37.5%) and resistant pattern followed by Proteus spp.(16.7%), Pseudomonas spp. 
(46.7%), Klebsiella spp. (35.3%) and Staphylococcus aureus (60%) respectively.  
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Table-5: Susceptibility pattern of Gentamicin against uropathogens among female UTI patients (n=961) 
Name of organisms 
Sensitive Resistant 
Number Percentage Number Percentage 
E. coli 550 67.5% 265 32.5% 
Proteus spp. 6 75.0% 2 25.0% 
Pseudomonas spp. 5 41.7% 7 58.3% 
Klebsiella spp. 42 63.6% 24 36.4% 
Enterobacter spp. 8 88.9% 1 11.1% 
Staphylococcus aureus 17 63.0% 10 37.0% 
Enterococcus spp. 7 41.2% 10 58.8% 
Acinetobacter spp. 1 100.0% 0 0.0% 
Citrobacter spp. 1 100.0% 0 0.0% 
Streptococcus Group B 1 100.0% 0 0.0% 
Serratia spp. 2 100.0% 0 0.0% 
Staph. saprophyticus 2 100.0% 0 0.0% 
Total 642 66.8% 319 33.2% 
In our study table-5 showed that Gentamicin sensitive against isolated uropathogenic bacteria in total female 
patients were 66.8% and rest of resistant 33.2%. All of them (100%) Acinetobacter spp., Citrobacter spp., 
Streptococcus Group B, Serratia spp. and Staph. saprophyticus were sensitive to Gentamicin but here the numbers 
were very few. On the other hand the most prevalent resistant organism was Enterococcus spp. (58.8%) but here 
the numbers were very few. By contrast of frequency, E. coli was the most significant organism which was 67.5% 
sensitive and 32.5 % resistant to Gentamicin. However, the other isolated bacterias sensitive pattern to Gentamicin 
followed by Proteus spp. (75%), Pseudomonas spp. (41.7%), Klebsiella spp. (63.6%), Enterobacter spp. (88.9%), 
Staph. aureus (63%) and Enterococcus spp. (41.2%) and resistant pattern followed by Proteus spp.(25%), 
Pseudomonas spp. (58.3%), Klebsiella spp. (36.4%), Enterobacter spp. (11.1%) and Staph. aureus (37%), 
respectively.  
 
IV. DISCUSSION 
This study aimed to evaluate the pattern of antimicrobial susceptibility of bacteria isolated from patients with UTI 
seen at the IBN SINA diagnostic center, Badda, Dhaka, Bangladesh. Moreover, we have identified the crucial 
bacterial species associated with UTI and described the profile of resistance to Gentamicin. It is important that 
clinicians are aware of the regional antibiotic resistance rates before initiating experimental antimicrobial therapy 
for UTI treatment, as it is well-described that urinary infection with a resistant pathogen is more likely to lead to 
bacteriological/clinical failures.(17) In our study, we tested total 12943 urine samples and 1236 (9.55%) were 
bacteriological positive and 11707 (90.45%) were bacteriological negative found.  
In our study we found The highest of the study subjects under goes to the 21-30 years age group (200 
patients=181 female + 19 male) and followed by 61-70 years age group (197 patients=124 female + 73 male), 41-
50 years age group (175 patients=149 female + 26 male), 51-60 years age group (168 patients= 130 females + 38 
males) and <10 years age group (156 patients= 103 females + 53 males) respectively. According to frequency in 
total infected patients, we saw that mostly female patients are affected by uropathogens in all the age groups in 
contrast male patients. It was noted that the highest frequency of UTIs observed in women when compared to men, 
which is often attributed to a shorter urethra that facilitates colonization by these microorganisms.(1) Most prevalent 
frequency of female and male patients affected by uropathogens was found in 21-30 years and 61-70 years age 
group respectively. However, there were found significant difference between the age groups and sex of urinary 
tract infection patients at 5% (P<0.05).  
In the fugure we saw the percentage of male patients were more porne in contrast female patients (19.3% > 
10.7%) under 10 years age groups. Our finding is supported by the fact that uncircumcised male infants appear to 
be at increased risk of UTIs in the first three months of life. In a study of 100 otherwise healthy infants ranging in 
age from five days to eight months and admitted to the hospital because of a first known UTI. Most of the UTIs in 
infants younger than three months of age were in males, but female infants predominated thereafter.(18) We also 
found in between 11-20, 21-30, 31-40 and 41-50 years of age group female UTI infection (8.6%, 18.8%, 11.8% 
and 15.5% respectively) is higher than male (1.8%, 6.9%, 5.8% and 9.5% respectively).  In between 51-60, 61-70 , 
71-80 and 81-90 years age male infection (13.8%, 26.5%, 13.8% and 1.8% respectively) is higher than female 
(13.5%, 12.9%, 5.8 % and 1.5% respectively). Above 90 years age female infection (0.8%) is higher than male 
(0.7%) but here number of patients were very few. The most predominat age gorup was 21-20 years in female 
patients. Incidence of infection in females increases directly with sexual activity and child-bearing. In the women, 
25-30% of women between 20-40 years of age will get UTIs. The anatomical relationship of the female urethra 
and the vagina makes it liable to trauma during sexual intercourse as well as bacteria been massaged up the urethra 
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into the bladder during pregnancy and child birth.  It has been reported in several studies that women who are 
sexually active, and especially if they use contraceptives, foams, gels, diaphragm and spermicides which are known 
to promote greater colonization of the vagina are at higher risk of developing UTIs.(1,19) Furthermore, another 
mechanism that could explain the lower frequency of UTI in men would be the prostatic fluid, which has 
antibacterial substances.(20) We got 961 (77.8%) female and 275 (22.2%) male patients. However, there were found 
significant difference between the percentage of age groups and sex of urinary tract infection patients at 5% 
(P<0.05). 
Table 2 showed that the most predominant organism E. coli 1037 (male 222 and female 815) found in UTI 
patients. According to number or percentage distribution, the second prevalent organism was Klebsiella spp. 83 
(male 17 & female 66) followed by Staphylococcus aureus 32 (male 5 and female 27), Pseudomonas spp. 27 (male 
15 and female 12), Enterococcus spp. 25 (male 8 and female 17), Proteus spp. 14 (male 6 and female 8) and 
Enterobacter spp. 10 (male 1 and female 9) respectively. In total bacteriologically positive cases, the most prone 
organism in male and female were E. coli (18.0% and 65.9 %) respectively. There is fecal contamination of 
periurethral area, then the bacteria spreads on ascending through the bladder and causes cystitis. These infections 
of the lower urinary tract, in some cases, can affect the kidneys and cause acute pyelonephritis, which consequently 
may result in bacteremia and sepsis.(21) Moreover, all the isolated organisms were found highest in female except 
Pseudomonas spp. in contrast male patients. On the other hand the study showed that the total 22.2% male patients 
and 77.8% female patients were found. Moreover, there were found significant difference between the isolated 
organism and sex of urinary tract infection patients at 5% (P<0.05). 
In this study, the urinary tract infections of female patients (961) were more prone to male patients (275). In 
male, the most predominant uropathogen were E. coli (80.7%) followed by Klebsiella spp. (6.2%), Pseudomonas 
spp. (5.5%), Enterococcus spp. (2.9%), Staphylococcus aureus (1.8%). In female, the most prevalent uropathogen 
were E. coli (84.8%) followed by Klebsiella spp. (6.9%), Staphylococcus aureus (2.8%), Enterococcus spp. (1.8%),   
Pseudomonas spp. (1.2%).. Several studies have shown that Escherichia coli is the major bacterial species 
associated with UTIs, and Klebsiella pneumoniae is the second most important bacteria in this type of infection.(1) 
The study noted that female patients were more infected by all of the isolated organism (E.coli, Klebsiella spp.. 
Staphylococcus aureus, Enterobacter spp, Serretia spp., Staphylococcus saprophyticus, Citrobacter spp. and 
Streptococcus Group B) except some organisms (Pseudomonas spp. and Enterococcus spp., Proteus spp. and 
Acinetobacter spp.) but here the number were very few. However, there were found significant difference between 
the percentage and frequency of isolated organism and sex of urinary tract infection patients at 5% (P<0.05). 
Treatment of urinary tract infections is becoming more complicated with an increase of the number of 
resistant strains to antibiotics and prevalence of antibiotic resistance mechanisms. Table-4 showed that Gentamicin 
sensitive against isolated uropathogenic bacteria in total male patients were 61.8% and rest of resistant 38.2%. All 
of them (100%) Acinetobacter spp. and Enterobacter spp. were sensitive to Gentamicin but here the numbers were 
very few. On the other hand the most prevalent resistant organism was Enterococcus spp. (62.5%). In contrast of 
frequency, E. coli was the most significant organism which was 62.6 % sensitive and 37.4 % resistant to 
Gentamicin. As Gentamicin very effective in most of the uropathogens, But it is very alarming subject to resistant 
a wide range of this drugs.  It had observed that horizontal gene transfer is a factor in the emergence and spread of 
antimicrobial resistance in clinical isolates. Consequently, it has been suggested that the high prevalence of 
resistance to a particular antibiotic does not always reflect antibiotic consumption in a given environment.(1,22) 
However, the other isolated bacteria’s sensitive pattern to Gentamicin followed by Proteus spp.(83.3%), 
Pseudomonas spp. (53.3%), Klebsiella spp. (64.7%), Staphylococcus aureus (40%) and Enterococcus spp. (37.5%) 
and resistant pattern followed by Proteus spp.(16.7%), Pseudomonas spp. (46.7%), Klebsiella spp. (35.3%) and 
Staphylococcus aureus (60%) respectively. There were no significant difference among the susceptibility pattern 
of Gentamicin, isolated organism and sex of the patients at 5% (P>0.05). 
Gentamicin sensitive against isolated uropathogenic bacteria in total female patients were 66.8% and rest of 
resistant 33.2% found in table-5. All of them (100%) Acinetobacter spp., Citrobacter spp., Streptococcus Group 
B, Serratia spp. and Staph. saprophyticus were sensitive to Gentamicin but here the numbers were very few. On 
the other hand the most prevalent resistant organism was Enterococcus spp. (58.8%) but here the numbers were 
very few. By contrast of frequency, E. coli was the most significant organism which was 67.5% sensitive and 32.5 % 
resistant to Gentamicin. However, the other isolated bacteria’s sensitive pattern to Gentamicin followed by Proteus 
spp.(75%), Pseudomonas spp. (41.7%), Klebsiella spp. (63.6%), Enterobacter spp. (88.9%), Staph. aureus (63%) 
and Enterococcus spp. (41.2%) and resistant pattern followed by Proteus spp.(25%), Pseudomonas spp. (58.3%), 
Klebsiella spp. (36.4%), Enterobacter spp. (11.1%) and Staph. aureus (37%), respectively.  There were no 
significant difference among the susceptibility pattern of Gentamicin, isolated organism and sex of the patients at 
5% (P>0.05). 
The knowledge on the regional pattern of bacterial resistance is critical to guide the medical staff to choose 
an appropriate antibiotic for the treatment of UTI patients.(23) Bacterial resistance has become a public health issue 
and has increasingly been associated with risk factors that put life in danger.(1) Awareness is needed of both the 
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population and health professionals about the importance for the correct use of antibiotics, and it is mandatory to 
take into account the result of antibiotics susceptibility tests. The Gentamicin use should be performed only after 
the microbial susceptibility confirmation, and it is necessary to find other alternatives for the empirical treatment. 
The bacterial resistance prevention can be performed through control measures that limit the spread of resistant 
bacteria and the rational use of antimicrobial policy. 
 
V. CONCLUSION 
In a nutshell, the results showed that there is a alarming subject of resistance of Gentamicin against UTI  patients 
among this areas (Badda, Gulshan, Baridhara, Rampura, Doyagonj, Gandaria,Jatrabari, Sayedabad, Dhaka, 
Bangladesh). Most of the bacteria were susceptible to Gentamicin. The prescribed Gentamicin antibiotic were still 
effective against the uropathogens, but should be reserved for only complicated UTIs and should use to follow the 
antibiotic guidelines in order to prevent emergence of multi drug resistant organisms. 
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